Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1237241

	registered interest
	date	23/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Urinary Tract Infections
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of catheter acquired urinary tract infections which develop into a gram negative bloodstream infection; and if he will make a statement.
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	uin	94467
	answer	answer is ministerial correction date of answer 22/10/2020 answer text <p>Public Health England’s (PHE’s) continuous routine laboratory surveillance does not include device use or procedures associated with urinary infections, such as urinary catheters. Therefore, no estimate has been made of the number of catheter-acquired urinary tract infections (CAUTIs) which develop into a gram-negative bloodstream infection.</p><p>No assessment has been made on the effect of CAUTIs on antimicrobial resistance and antibiotic over-prescription.</p><p>However, PHE’s English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) is working with the National Health Service and across sectors, to develop and maintain surveillance systems for monitoring trends in antimicrobial use and resistance in England. Further details are available in the ESPAUR report 2018-19 at the following link:</p><p><a href="https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report" target="_blank">https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 94468 94470 question first answered 22/10/2020 16:03:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	4474 label Biography information for Kevin Hollinrake

1237242

	registered interest
	date	23/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Urinary Tract Infections
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of catheter acquired urinary tract infections on (a) antimicrobial resistance and (b) antibiotic over-prescription; and if he will make a statement.
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	uin	94468
	answer	answer is ministerial correction date of answer 22/10/2020 answer text <p>Public Health England’s (PHE’s) continuous routine laboratory surveillance does not include device use or procedures associated with urinary infections, such as urinary catheters. Therefore, no estimate has been made of the number of catheter-acquired urinary tract infections (CAUTIs) which develop into a gram-negative bloodstream infection.</p><p>No assessment has been made on the effect of CAUTIs on antimicrobial resistance and antibiotic over-prescription.</p><p>However, PHE’s English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) is working with the National Health Service and across sectors, to develop and maintain surveillance systems for monitoring trends in antimicrobial use and resistance in England. Further details are available in the ESPAUR report 2018-19 at the following link:</p><p><a href="https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report" target="_blank">https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 94467 94470 question first answered 22/10/2020 16:03:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	4474 label Biography information for Kevin Hollinrake

1237244

	registered interest
	date	23/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Urinary Tract Infections
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to World Patient Safety Day 2020, what steps his Department is taking to improve the (a) tracking and (b) prevention of catheter acquired urinary tract infections; and if he will make a statement.
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	uin	94470
	answer	answer is ministerial correction date of answer 22/10/2020 answer text <p>Public Health England’s (PHE’s) continuous routine laboratory surveillance does not include device use or procedures associated with urinary infections, such as urinary catheters. Therefore, no estimate has been made of the number of catheter-acquired urinary tract infections (CAUTIs) which develop into a gram-negative bloodstream infection.</p><p>No assessment has been made on the effect of CAUTIs on antimicrobial resistance and antibiotic over-prescription.</p><p>However, PHE’s English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) is working with the National Health Service and across sectors, to develop and maintain surveillance systems for monitoring trends in antimicrobial use and resistance in England. Further details are available in the ESPAUR report 2018-19 at the following link:</p><p><a href="https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report" target="_blank">https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 94467 94468 question first answered 22/10/2020 16:03:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	4474 label Biography information for Kevin Hollinrake

1186650

	registered interest
	date	19/03/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antibiotics: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle the rise of carbapenem-resistant bacteria in secondary care.
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	uin	32282
	answer	answer is ministerial correction date of answer 27/04/2020 answer text <p>Carbapenemase-producing Enterobacteriaceae (CPE) are carbapenem-resistant infections with the ability to transfer resistance to different bacterial species. Public Health England conducts monitoring and surveillance of these infections and publishes toolkits to support acute and non-acute organisations to prevent and control the spread of CPE.</p><p>The Government recognises that identifying where carbapenemase-producing Gram-negative infections occur, and acting to prevent them, is essential to maintain the effectiveness of our most important antibiotics. Work is underway to add these infections to the list of notifiable diseases as part of our national action plan for antimicrobial resistance.</p><p>NHS England and NHS Improvement continues to work to reduce the burden of all healthcare-associated infections and is tasked with delivering the Government’s ambition to halve all healthcare associated Gram-negative blood stream infections by 2023-24.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/04/2020 13:08:29 answering member 4380 label Biography information for Jo Churchill
	tabling member	4474 label Biography information for Kevin Hollinrake